WFD Ventures

Investor type Venture Capital
Founders William F. Doyle

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$20M
Portfolio companies 6
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.40
Exits 3
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical Device
  • Drug Delivery
Summary

The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.

The high activity for fund was in 2015. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies. The higher amount of exits for fund were in 2017. Opposing the other organizations, this WFD Ventures works on 4 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the WFD Ventures, startups are often financed by New York Angels, F2 Ventures, Blackfin Technology. The meaningful sponsors for the fund in investment in the same round are Avista Capital Partners, General Catalyst, The Entrepreneurs' Fund. In the next rounds fund is usually obtained by Avista Capital Partners, Entrepreneurs Fund, ZGC Shiner Investment.

Among the most successful fund investment fields, there are Software, Biotechnology. The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight BionXu2122 Medical Technologies, ProterixBio, ImaCor.

The fund was created by William F. Doyle.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of WFD Ventures:
Typical Co-investors
WFD Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after WFD Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Dainippon Sumitomo Pharma Japan, Osaka, Osaka Prefecture
Diehl Ventures Bayern, Germany, Nuremberg
eCatalogs California, Los Angeles, United States
Foresight 4 VCT plc -
Hankang Capital China, Shanghai
Security Pacific National Bank California, Los Angeles, United States
Wolverine Trading Chicago, Illinois, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

BionX™ Medical Technologies

Biotechnology
Health Care
Pharmaceutical
$17M23 Dec 2015 Massachusetts, United States

OptiNose

Biotechnology
Drug Delivery
Medical Device
Other Devices and Supplies
Pharmaceutical
$30M06 Oct 2015 Oslo

Avisena

Health Care
Management Information Systems
SaaS
Software
$517K19 Mar 2015 Miami, Florida, United States

OptiNose

Biotechnology
Drug Delivery
Medical Device
Other Devices and Supplies
Pharmaceutical
$35M05 Aug 2014 Oslo

BionX™ Medical Technologies

Biotechnology
Health Care
Pharmaceutical
$17M13 Sep 2012 Massachusetts, United States

ProterixBio

Biotechnology
Health Diagnostics
Pharmaceutical
$25M14 Jun 2010 Massachusetts, United States

OptiNose

Biotechnology
Drug Delivery
Medical Device
Other Devices and Supplies
Pharmaceutical
$48M07 Jun 2010 Oslo, Norway

BionX™ Medical Technologies

Biotechnology
Health Care
Pharmaceutical
$20M21 Oct 2009 Massachusetts, United States

ImaCor

Biotechnology
Health Care
Medical Device
$5M21 Feb 2009 New York, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent WFD Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: